Detalles de la búsqueda
1.
Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
Antimicrob Agents Chemother
; 60(2): 797-805, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596939
2.
Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles.
Antimicrob Agents Chemother
; 54(12): 5028-41, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20855728
Resultados
1 -
2
de 2
1
Próxima >
>>